ELLOGON AI

ellogon-ai-logo

Ellogon.AI develops automated biomarkers from pathology biopsies and genomic data for personalised immunotherapy with the power of big and rich data, cutting-edge algorithms and a world-class research team.

#SimilarOrganizations #People #Financial #Website #More

ELLOGON AI

Industry:
Artificial Intelligence Health Care Health Diagnostics Machine Learning Software

Founded:
2019-05-01

Address:
Amsterdam, Noord-Holland, The Netherlands

Country:
The Netherlands

Website Url:
http://www.ellogon.ai

Total Employee:
1+

Status:
Active

Contact:
+31 611 480821

Email Addresses:
[email protected]

Total Funding:
550 K EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins


Similar Organizations

pera-labs-logo

Pera Labs

Pera Labs develops digiceuticals and AI-powered solutions for fertility.

Current Employees Featured

efstratios-gavves_image

Efstratios Gavves
Efstratios Gavves Co-Founder & Chief Science Officer @ Ellogon AI
Co-Founder & Chief Science Officer

evangelos-kanoulas_image

Evangelos Kanoulas
Evangelos Kanoulas Co-Founder & Chief Operating Officer @ Ellogon AI
Co-Founder & Chief Operating Officer

robert-kuipers_image

Robert Kuipers
Robert Kuipers Chief Executive Officer @ Ellogon AI
Chief Executive Officer

jonas-teuwen_image

Jonas Teuwen
Jonas Teuwen CTO @ Ellogon AI
CTO

Founder


efstratios-gavves_image

Efstratios Gavves

evangelos-kanoulas_image

Evangelos Kanoulas

Investors List

innovatiefonds-noord-holland_image

Innovatiefonds Noord-Holland

Innovatiefonds Noord-Holland investment in Convertible Note - Ellogon AI

Official Site Inspections

http://www.ellogon.ai

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ellogon AI"

Ellogon

The core Ellogon.AI team is strengthened by two crucial partnerships. In 2020 we closed a partnership with the NKI, currently ranked #6 worldwide in cancer research. This partnership โ€ฆSee details»

About us - Ellogon

The Ellogon.AI team shares a single passion: contribute to improving the outcome of cancer. To realize this we have put together a team with all the right ingredients. We are happy to โ€ฆSee details»

The AI - Ellogon

By exploiting sparse-shot and self-supervised neural dynamics during the extremely high-dimensional optimization, Ellogonโ€™s Exclusive Deep Learning identifies millions of cells and โ€œsuper-humanโ€ patterns in raw H&E and PD-L1 โ€ฆSee details»

Ellogon AI - Crunchbase Company Profile & Funding

Ellogon AI may be growing as it has recently secured a significant amount of funding, specifically โ‚ฌ1M, which is a strong indicator of investor confidence and financial backing to advance its โ€ฆSee details»

Ellogon.AI Company Profile 2024: Valuation, Funding & Investors

Ellogon.AI General Information Description. Developer of automated biomarkers from pathology biopsies and genomic data designed for personalized immunotherapy. The company's โ€ฆSee details»

Ellogon AI - Org Chart, Teams, Culture & Jobs - The Org

View Ellogon AI's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Ellogon.AI - LinkedIn

ELLOGON.AI is working on personalizing immunotherapy with the power of big and rich data, cutting-edge algorithms and a world-class research and development team.See details»

Ellogon.AI - Overview, News & Similar companies | ZoomInfo.com

Who is Ellogon.AI. ELLOGON.AI is a startup founded by Prof. E. Kanoulas and Assoc. Prof. E. Gavves, at the University of Amsterdam. The mission of Ellogon.AI is to de velop automated โ€ฆSee details»

Artificial intelligence expert to boost growth of a high-potential ...

Dec 27, 2023 Ellogon AI is an innovative start-up established in 2019 as a spin-off from University of Amsterdam, by leading academic experts in artificial intelligence, medical โ€ฆSee details»

Supporting SMEs in attracting top-notch human capital: The โ€ฆ

Jun 9, 2021 ELLOGON.AI is one of the SMEs receiving the help of an innovation associate. ELLOGON.AI is working on personalising immunotherapy with the power of big and rich data โ€ฆSee details»

Innovation Fund Noord Holland finances UvA-IvI spin-off Ellogon.AI

Aug 16, 2023 Ellogon.AI develops AI technology for the diagnosis of cancer immunotherapy and is founded by Efstratios Gavves and Evangelos Kanoulas, researchers at the Informatics โ€ฆSee details»

Ellogon.ai is ready to conquer health market

Apr 26, 2024 Ellogon.ai has had a hectic few months. In February, the company won the regional preliminaries of the Zorginnovatieprijs.In doing so, they also won a year-long โ€ฆSee details»

Ellogon AI - Contacts, Employees, Board Members, Advisors

Ellogon AI has 4 current employee profiles, including Co-Founder & Chief Science Officer Efstratios Gavves. Efstratios Gavves Co-Founder & Chief Science Officer Evangelos Kanoulas โ€ฆSee details»

Ellogon.AI | Matrix

Ellogon.AI assists medical experts in selecting the right patient for cancer immunotherapy. We do this by fast and accurate quantification of relevant biomarkers by use of a breakthrough deep โ€ฆSee details»

ELLOGON.AI - Company Profile - Tracxn

Oct 25, 2024 ELLOGON.AI ranks 55th among 199 active competitors. 59 of its competitors are funded while 10 have exited. Overall, ELLOGON.AI and its competitors have raised over โ€ฆSee details»

Ellogon AI - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 24, 2021: ... Seed Round - โ€ฆSee details»

Ellogon.AI secures โ‚ฌ1M to advance immunotherapy innovation - I โ€ฆ

Ellogon.AI's success in securing a significant investment reaffirms its position as a leader in AI-driven healthcare innovation in Amsterdam. With the continued support of investors and โ€ฆSee details»

Ellogon

3 days ago Welcome to Ellogon. If you've read anything at all about Natural Language Processing (NLP), you'll probably know at least three things: NLP is an extremely exciting and โ€ฆSee details»

News - Ellogon

EIDOS runs on UbiOps 29 December 2022. EIDOS runs on UbiOps 29 December 2022 Jessica Hot off the press! Working with the Netherlands Cancer Institute, Ellogon.AI has developed a โ€ฆSee details»

Laying the Foundation for Gen AI Success | BCG - Boston โ€ฆ

21 hours ago An organizationโ€™s enterprise AI foundation is a base that supports the GenAI activity of the entire organization, not just early adopters or a few product lines. It is structured โ€ฆSee details»

linkstock.net © 2022. All rights reserved